UBS Cuts Price Target on Mattress Firm (MFRM) to $57 Following 2Q15

Piper Jaffray Cuts Price Target on Mattress Firm (MFRM) Following 2Q15 Earnings Results

September 14, 2015 8:18 AM EDT

Piper Jaffray reiterated a Neutral rating on Mattress Firm Holding Corp. (NASDAQ: MFRM), and cut the price target to $47.00 (from $62.00), following the company's 2Q15 earnings results. EPS was reported at $0.67, missing consensus of $0.72.

Analyst Peter Keith commented, "We are maintaining our Neutral... More

BofA/Merrill Lynch Downgrades Mattress Firm Holding Corp. (MFRM) to Neutral

September 14, 2015 7:49 AM EDT

BofA/Merrill Lynch downgraded Mattress Firm Holding Corp. (NASDAQ: MFRM) from Buy to Neutral with a price target of $55.00.

For an analyst ratings summary and ratings history on Mattress Firm Holding Corp.... More

Wedbush Cuts Price Target on Mattress Firm (MFRM) to $50 Following 5c EPS Miss

September 14, 2015 7:34 AM EDT

Wedbush maintained a Neutral rating on Mattress Firm Holding Corp. (NASDAQ: MFRM), and cut the price target to $50.00 (from $60.00), following the company's 2Q15 earnings results. Adjusted EPS missed consensus by $0.05 at $0.67. The company cut FY adjusted EPS guidance by $0.25 at the high end from $2.70 to $2.45.... More

Notable 52-Week Highs and Lows 9/11: (CNCE) (INCY) (MRTX) High; (MRVL) (FNSR) (ZUMZ) Low

September 11, 2015 3:17 PM EDT

52-Week High:Concert Pharmaceuticals (Nasdaq: CNCE) $19.64. Concert Pharmaceuticals gaining after it presentation at the Baird 2015 Healthcare Conference yesterday. The company will also be presenting at the Ladenburg Thalmann 2015 Healthcare Conference on September 29th.

Incyte Corporation (Nasdaq: INCY) $131.00. Incyte continuing higher on speculation that it might be a takeover target for Gilead Sciences.

Mirati Therapeutics (Nasdaq: MRTX) $42.88. Mirati Therapeutics adding to gains... More

Pre-Open Stock Movers 09/11: (LTRE) (PGI) (ZSPH) Higher; (CHKE) (MRVL) (ZUMZ) Lower (more...)

September 11, 2015 9:35 AM EDT

Learning Tree International (NASDAQ: LTRE) 70% HIGHER; Mill Road offers to buy company for $1.80/share.

Cherokee (NASDAQ: CHKE) 34.4% LOWER; reported Q2 EPS of $0.22, $0.02 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $8.62 million. Cherokee Global Brands also announced that Target Corporation has elected not to renew the license of the Cherokee brand in the US, which will expire at the end of its... More

Mattress Firm (MFRM) Announces President, COO Promotions

September 11, 2015 7:36 AM EDT

Mattress Firm (NASDAQ: MFRM) announced that Ken Murphy has been promoted to president and Rob Killgore to chief operating officer. The Company also announced that Dale Carlsen will assume the role of executive vice chairman and chief philanthropy officer. In this role Mr. Carlsen will work closely with the senior executive team on key strategic initiatives, vendor relations, mergers and acquisitions, and community engagement. This new structure is the next step in the integration of the Sleep Train organization and is intended to drive future growth. These changes are effective... More

Mattress Firm (MFRM) Tops Q2 EPS by 11c; Updates FY15 Outlook

September 11, 2015 7:32 AM EDT

Mattress Firm (NASDAQ: MFRM) reported Q2 EPS of $0.83, $0.11 better than the analyst estimate of $0.72. Revenue for the quarter came in at $661.1 million versus the consensus estimate of $663.58 million.

Comparable-store sales growth in the prior year period was 9.7%.

Mattress Firm sees FY2015 EPS of... More

Trading Radar for 9/10: Kroger (KR), Mattress Firm (MFRM), Brady Corp. (BRC), Mechel (MTL) Report

September 10, 2015 2:17 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

PPI - Street sees (0.1%)Core PPI - Street sees 0.1%

Earnings:

Biota Pharma (Nasdaq:... More